Nasenimplantat
Anmelder: Stryker Corporation 🇺🇸
Details
- Veröffentlichungs-Nr.
- EP4714372
- Anmeldetag
- 23. September 2016
- Veröffentlichung
- 25. März 2026
- Rechtsraum
- EP
- IPC
- A61B17/24(SAIDI IYAD S et al.)(EATON DONALD J et al.)
Abstract
A nasal implant comprises an implant body comprising a distal end, a proximal end, a central portion disposed between the proximal end and the distal end, a core made of a degradable material, and a coating on an outer surface of the implant core. The central portion comprises a plurality of ribs. The coating comprises hydrophobic material which is bioabsorbable, wherein the coating and the implant core do not deliver a pharmaceutical agent or a drug. The nasal implant further comprises a first arm disposed at the distal end, the first arm having a proximal end fixed to the body and a distal end not fixed to the body, and a second arm having a proximal end fixed to the body and a distal end not fixed to the body. The distal end of the first arm is adapted to move away from a central longitudinal axis of the body from a delivery configuration toward a deployed configuration. The distal end of the second arm is adapted to move away from a central longitudinal axis of the body from a delivery configuration toward a deployed configuration, wherein the first and second arms are biased toward their deployed configuration.
Anmelder
- Firma
- Stryker Corporation
- Land
- 🇺🇸 USA
Irische Tochtergesellschaft des US-Medizintechnikkonzerns Stryker, koordiniert europäische Geschäfte mit Implantaten, chirurgischen Instrumenten und Ausrüstung für Krankenhäuser.
1.652 Patente in unserer Datenbank
Fachgebiete
Wuesthoff & Wuesthoff wurde 1927 in Berlin von Dr. Franz und Dr. Freda Wuesthoff gegründet, die erste deutsche Patentanwältin, und zog 1949 nach München. Schwerpunkte liegen in Biotechnologie und Life Sciences, beraten wird auch auf Chinesisch, Koreanisch und Japanisch.